Blood pressure pill may stop knee scarring after ACL surgery
NCT ID NCT07135687
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether losartan, a common blood pressure medicine that also reduces scarring, can prevent abnormal scar tissue (arthrofibrosis) in the knee after ACL reconstruction. About 144 adults having ACL surgery will take losartan or a placebo. The main goal is to see if it helps maintain knee range of motion over 12 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACL INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Rush University Medical Center
Chicago, Illinois, 60612, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Osteoporosis drug could strengthen knee rebuilds
- Which workout rebuilds a repaired knee best? a head-to-head trial of movement vs stability training
- Stem cell byproduct may boost ACL graft healing — trial puts it to the test
- Bone scaffold may help ACL grafts heal stronger
- Wearable shirt tracks surgeon fatigue during knee surgery
- Vibration therapy may reduce second ACL injury risk